Exploring NPM1P51 as a key biomarker for glaucoma by integrating differential gene expression analysis and artificial neural network models
Authors:
- VaishnaviVAVaishnavi
- Prekshi GargPGPrekshi Garg
- 10 January 2026
- journal article
- Published by Elsevier in Gene Expression Patterns
- Vol. 57, 119406
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Transcriptome Derived Artificial neural networks predict PRRC2A as a potent biomarker for epilepsyJournal of Genetic Engineering and Biotechnology, 2025
- The relationship between intraocular pressure and glaucoma: An evolving conceptProgress in Retinal and Eye Research, 2024
- Protocol for identifying differentially expressed genes using the RumBall RNA-seq analysis platformSTAR Protocols, 2024
- TRPV4 antagonist suppresses retinal ganglion cell apoptosis by regulating the activation of CaMKII and TNF-α expression in a chronic ocular hypertension rat modelInternational Immunopharmacology, 2024
- Feature selection strategy for machine learning methods in building energy consumption predictionEnergy Reports, 2022
- Adaptive responses to neurodegenerative stress in glaucomaProgress in Retinal and Eye Research, 2021
- Artificial Neural Networks for Neuroscientists: A PrimerNeuron, 2020
- Primary angle closure glaucoma: What we know and what we don’t knowProgress in Retinal and Eye Research, 2017
- Significance of optineurin mutations in glaucoma and other diseasesProgress in Retinal and Eye Research, 2016
- Mechanisms of retinal ganglion cell injury and defense in glaucomaExperimental Eye Research, 2010